RxDoctor Payments Data

Traci Jensen, DO

Family Medicine · Sun City, AZNPI 1053595041

Payments from drug & device makers

$420in general payments, 2019–2025

Across 17 payments — averaging $24.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$182
  • AstraZeneca$93
  • Lilly USA, LLC$34
  • Amgen$30
  • AbbVie$22
  • Teva Pharmaceuticals USA, Inc.$18
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$420100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$420 in reported general payments places this provider in the 55th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$61,274
Medicare patients
291
Services billed
1,334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide13$21,339
MounjaroTirzepatide14$17,684
JardianceEmpagliflozin16$12,384
Albuterol Sulfate HfaAlbuterol Sulfate63$1,871
Atorvastatin Calcium180$1,404
Levothyroxine Sodium166$1,318
Rosuvastatin Calcium117$1,152
Losartan Potassium101$991
SynthroidLevothyroxine Sodium14$915
Lisinopril136$826
Sertraline Hcl60$625
Amlodipine Besylate127$606
Metoprolol Succinate54$597
Escitalopram Oxalate49$583
Gabapentin24$558

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$34$17,68414 claims
AbbVieSynthroid$22$91514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Sun City

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →